JNJ-10198409
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
627518-40-5
PDGFR
Protein Tyrosine Kinase
COC1=CC2=C (C=C1OC) C3=C (C2) C (=N[NH]3) NC4=CC=CC (=C4) F
C18H16FN3O2
JNJ-10198409, a relatively selective, orally active, and ATP competitive PDGF-RTK (platelet-derived growth factor receptor tyrosine kinase) inhibitor with IC50 of 2 nM, is a dual-mechanism, antiangiogenic, and tumor cell antiproliferative agent, has good activity against PDGFRβ kinase and PDGFRα kinase with IC50 of 4.2 and 45 nM, respectively.
3 years -20°C powder
Beschrijving
JNJ-10198409 Beschikbaar in 5 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
CD35 (CR1) mouse monoclonal antibody, clone J3D3, Azide Free
BM2364
0.2 mg
Anti-KIR2DL1 (Rabbit, Monoclonal, Rabbit mAb)
A115392
100 µL
Stains-all
03943-5
5 g
Sudan Blue II;Oil Blue 35
TRC-S688913-500MG
500 mg
Nile Blue A
N8430-01
1 g
Anti-APOE2 mouse monoclonal antibody
TD-AB0132
100 µg
Human Apolipoprotein E2 (Apo E2) Antibody
22210-05011
150 µg
MycoBlue Mycoplasma Detector
D101-02
50 Reactions